1. Home
  2. OVID vs CASI Comparison

OVID vs CASI Comparison

Compare OVID & CASI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OVID
  • CASI
  • Stock Information
  • Founded
  • OVID 2014
  • CASI 1991
  • Country
  • OVID United States
  • CASI China
  • Employees
  • OVID N/A
  • CASI N/A
  • Industry
  • OVID Biotechnology: Pharmaceutical Preparations
  • CASI Biotechnology: Pharmaceutical Preparations
  • Sector
  • OVID Health Care
  • CASI Health Care
  • Exchange
  • OVID Nasdaq
  • CASI Nasdaq
  • Market Cap
  • OVID 20.6M
  • CASI 20.5M
  • IPO Year
  • OVID 2017
  • CASI 1996
  • Fundamental
  • Price
  • OVID $0.33
  • CASI $1.12
  • Analyst Decision
  • OVID Strong Buy
  • CASI Strong Buy
  • Analyst Count
  • OVID 4
  • CASI 1
  • Target Price
  • OVID $3.13
  • CASI $4.00
  • AVG Volume (30 Days)
  • OVID 1.7M
  • CASI 302.8K
  • Earning Date
  • OVID 08-12-2025
  • CASI 08-15-2025
  • Dividend Yield
  • OVID N/A
  • CASI N/A
  • EPS Growth
  • OVID N/A
  • CASI N/A
  • EPS
  • OVID N/A
  • CASI N/A
  • Revenue
  • OVID $548,000.00
  • CASI $31,368,000.00
  • Revenue This Year
  • OVID N/A
  • CASI N/A
  • Revenue Next Year
  • OVID $5.32
  • CASI N/A
  • P/E Ratio
  • OVID N/A
  • CASI N/A
  • Revenue Growth
  • OVID 15.61
  • CASI 8.39
  • 52 Week Low
  • OVID $0.24
  • CASI $1.09
  • 52 Week High
  • OVID $1.47
  • CASI $7.67
  • Technical
  • Relative Strength Index (RSI)
  • OVID 55.40
  • CASI 29.29
  • Support Level
  • OVID $0.29
  • CASI $1.22
  • Resistance Level
  • OVID $0.35
  • CASI $1.42
  • Average True Range (ATR)
  • OVID 0.03
  • CASI 0.28
  • MACD
  • OVID 0.00
  • CASI -0.04
  • Stochastic Oscillator
  • OVID 74.23
  • CASI 5.49

About OVID Ovid Therapeutics Inc.

Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.

About CASI CASI Pharmaceuticals Inc.

CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.

Share on Social Networks: